Ellington Credit (NYSE:EARN – Get Free Report) and Biosig Technologies (NASDAQ:STEX – Get Free Report) are both small-cap finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, dividends, valuation and institutional ownership.
Analyst Ratings
This is a summary of current recommendations for Ellington Credit and Biosig Technologies, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Ellington Credit | 0 | 1 | 1 | 0 | 2.50 |
| Biosig Technologies | 1 | 0 | 1 | 0 | 2.00 |
Ellington Credit currently has a consensus target price of $5.50, suggesting a potential upside of 27.17%. Biosig Technologies has a consensus target price of $4.00, suggesting a potential upside of 490.32%. Given Biosig Technologies’ higher possible upside, analysts plainly believe Biosig Technologies is more favorable than Ellington Credit.
Insider and Institutional Ownership
Risk and Volatility
Ellington Credit has a beta of 1.28, indicating that its stock price is 28% more volatile than the S&P 500. Comparatively, Biosig Technologies has a beta of 2.01, indicating that its stock price is 101% more volatile than the S&P 500.
Profitability
This table compares Ellington Credit and Biosig Technologies’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Ellington Credit | -70.52% | N/A | N/A |
| Biosig Technologies | N/A | -462.48% | -307.38% |
Valuation & Earnings
This table compares Ellington Credit and Biosig Technologies”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Ellington Credit | $51.80 million | 3.19 | -$38.85 million | ($0.98) | -4.41 |
| Biosig Technologies | $40,000.00 | 1,972.83 | -$462.77 million | ($9.05) | -0.07 |
Ellington Credit has higher revenue and earnings than Biosig Technologies. Ellington Credit is trading at a lower price-to-earnings ratio than Biosig Technologies, indicating that it is currently the more affordable of the two stocks.
Summary
Ellington Credit beats Biosig Technologies on 7 of the 13 factors compared between the two stocks.
About Ellington Credit
Ellington Credit Company, a real estate investment trust, acquires, invests in, and manages residential mortgage-and real estate-related assets. It acquires and manages residential mortgage-backed securities (RMBS), including agency pools and agency collateralized mortgage obligations (CMOs); and non-agency RMBS, such as non-agency CMOs, such as investment grade and non-investment grade. The company has elected to be taxed as a real estate investment trust. As a result, it would not be subject to corporate income tax on that portion of its net income that is distributed to shareholders. The company was formerly known as Ellington Residential Mortgage REIT and changed its name to Ellington Credit Company in April 2024. Ellington Credit Company was incorporated in 2012 and is based in Old Greenwich, Connecticut.
About Biosig Technologies
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company’s proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.
Receive News & Ratings for Ellington Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ellington Credit and related companies with MarketBeat.com's FREE daily email newsletter.
